日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Synthesis, molecular docking, and in vitro activity of a novel angiotensin-converting enzyme 2 inhibitor, LMS1007: a potential molecule in Covid-19 and cancer treatments.

新型血管紧张素转换酶 2 抑制剂 LMS1007 的合成、分子对接和体外活性:一种在 Covid-19 和癌症治疗中具有应用潜力的分子

Saadah Loai, Abu Deiab Ghina'a, Al-Balas Qosay, Basheti Iman

Machine learning assessment of vildagliptin and linagliptin effectiveness in type 2 diabetes: Predictors of glycemic control

利用机器学习评估维格列汀和利格列汀治疗2型糖尿病的疗效:血糖控制的预测因子

Esaifan, Hanin A; Saadah, Loai M; Abu Hammour, Khawla; Abu Farha, Rana K

Computational medicinal chemistry role in clinical pharmacy education: Ingavirin for coronavirus disease 2019 (COVID-19) discovery model

计算药物化学在临床药学教育中的作用:以2019冠状病毒病(COVID-19)的英加韦林发现模型为例

Saadah, Loai M; Deiab, Ghina'a I Abu; Al-Balas, Qosay A; Basheti, Iman A

Maximizing acceptance of clinical pharmacy recommendations to reduce length of hospital stay in a private hospital from Amman, Jordan

约旦安曼一家私立医院如何最大限度地采纳临床药学建议以缩短住院时间

Saadah, Loai M; Khan, Amer H; Syed Sulaiman, Syed Azhar; Bashiti, Iman A

Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein

肌肽对抗新型冠状病毒(nCoV):与宿主血管紧张素转化酶2(ACE2)和病毒刺突蛋白共结晶的分子对接和建模

Saadah, Loai M; Deiab, Ghina'a I Abu; Al-Balas, Qosay; Basheti, Iman A

Effectiveness of Liraglutide in Type II Diabetes Mellitus Management: Experience in Emirati Patients

利拉鲁肽在 II 型糖尿病管理中的疗效:阿联酋患者的经验

Ghuman, Nasrullah K; Saadah, Loai M; Al Najjar, Majdi S; Shaheen, Duha Y; Am, Shady I; Al Ali, Mouza M